Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
9.74M
-
Shares change
-
+3M
-
Total reported value, excl. options
-
$126M
-
Value change
-
+$40.3M
-
Number of buys
-
43
-
Number of sells
-
-8
-
Price
-
$12.96
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2020
55 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q2 2020.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.74M shares
of 44.5M outstanding shares and own 21.86% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.03M shares), Essex Woodlands Management, Inc. (1.39M shares), RTW INVESTMENTS, LP (1.36M shares), Alyeska Investment Group, L.P. (725K shares), COWEN AND COMPANY, LLC (409K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (325K shares), Pentwater Capital Management LP (277K shares), BlackRock Inc. (265K shares), SANDERS MORRIS HARRIS LLC (264K shares), and Opaleye Management Inc. (250K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.